ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Kaempferol attenuated diabetic nephropathy by reducing apoptosis and promoting autophagy through AMPK/mTOR pathways

Sheng, Hongqin; Zhang, Duo; Zhang, Jiaqi; Zhang, Yanmei; Lu, Zhaoyu; Mao, Wei; Liu, Xusheng; Zhang, Lei*广州中医药大学
Frontiers in Medicine2022-11-30DOI: 10.3389/fmed.2022.986825
9被引27阅读
引用收藏
分享

摘要

IntroductionRenal podocyte injury, apoptosis and autophagy are involved in the occurrence and development of diabetic nephropathy (DN). Kaempferol (KPF) has the promotion of autophagy and inhibition of apoptosis properties in the development of miscellaneous diseases, but these functions in DN have not yet been elucidated. MethodsWe used db/db mice to evaluate the protective role of KPF on DN. The anti-DN effect of KPF was evaluated by urine albumin-to-creatinine ratio and pathological changes of kidney tissue. Injury of podocytes was observed through Transmission electron microscopy. Immunofluorescence, Western blot, and Immunohistochemistry were used to detect the protein expression of podocyte-associated molecules, autophagy, and AMPK/mTOR pathway. ResultsWe demonstrated that KPF treatment significantly attenuated diabetes-induced albuminuria and glycolipid metabolism dysfunction. In addition, KPF alleviated mesangial matrix expansion, glomerular basement membrane thickening and loss or fusion of podocytes. Mechanistically, KPF treatment regulated the expression of autophagic proteins (upregulated LC3II, Beclin-1, Atg7 and Atg 5, and downregulated p62/SQSTM1), accompanied by inhibited renal apoptosis (downregulated Caspase 3 and Bax, and upregulated Bcl-2). KPF could significantly regulate the AMPK/mTOR signaling pathways by increasing p-AMPK and decreasing p-mTOR expressions. DiscussionIn conclusion, KPF might have a protective effect on DN through reduced apoptosis and enhanced podocytes autophagy, which were correlated with regulating AMPK/mTOR pathways.

学科与关键词

关键词
diabetic nephropathyKaempferolapoptosisautophagyAMPKmTOR pathway
相关
加载中…
  • Dapagliflozin alleviates advanced glycation end product induced podocyte injury through AMPK/mTOR mediated autophagy pathway
    Yang, Lei; Liang, Baozhu; Li, Jingxin; Zhang, Xiaoyan; Chen, Hong; Sun, Jia; Zhang, Zhen*Cellular Signalling, 2022, 90: 110206.被引 22
  • Klotho protects against diabetic kidney disease via AMPK- and ERK-mediated autophagy
    Xue, Meng; Yang, Feng; Le, Ying; Yang, Yanlin; Wang, Bingsen; Jia, Yijie; Zheng, Zongji; Xue, Yaoming*Acta Diabetologica, 2021, 58(10): 1413-1423.被引 23
  • PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease
    Zhang, Zongwei; Liang, Wei*; Luo, Qiang; Hu, Hongtu; Yang, Keju; Hu, Jijia; Chen, Zhaowei; Zhu, Jili; Feng, Jun; Zhu, Zijing; Chi, Qingjia; Ding, Guohua*Frontiers in Endocrinology, 2022, 12: 797025.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Medicine
发表日期
2022-11-30
卷期
第 9 卷
页码
986825
DOI
10.3389/fmed.2022.986825
期刊等级
3区
成果收录
SCIE
资助标注
State Key Laboratory of Dampness Syndrome of Chinese Medicine; National Natural Science Foundation of China; Guangzhou Science and Technology Project; [SZ2021ZZ16]; [81603717]; [202206010076]

作者

  • S

    Sheng, Hongqin (第一作者)

    2 · guangzhou univ chinese med

  • Z

    Zhang, Duo

    2 · guangzhou univ chinese med

查看全部 8 位作者收起作者
  • Z

    Zhang, Jiaqi

    2 · guangzhou univ chinese med

  • Z

    Zhang, Yanmei

    2 · guangzhou univ chinese med

  • L

    Lu, Zhaoyu

    2 · guangzhou univ chinese med

  • M

    Mao, Wei

    2 · guangzhou univ chinese med

  • L

    Liu, Xusheng

    2 · guangzhou univ chinese med

  • Z

    Zhang, Lei (通讯)

    2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417